Monoamine Oxidase Inhibitor Toxicity

OVERVIEW

Monoamine Oxidase Inhibitor (MAOI) Toxicity:

  • produces a hyperadrenergic syndrome from inability to inactivate noradrenaline
  • may contribute to serotonin toxidrome

CLINICAL FEATURES

  • mydriasis
  • flushing
  • diaphoresis
  • tachycardia
  • hypertension
  • hyperthermia
  • muscular rigidity
  • agitation
  • delirium
  • seizures

-> hypotension from adrenergic depletion

MANAGEMENT

Resuscitate

  • seizures may require intubation
  • haemodynamic instability may necessitate ventilation

Acid-base and Electrolytes

  • cool if hyperthermic

Specific Treatment

  • consider activated charcoal if present within 1 hour
  • sodium nitroprusside -> hypertension
  • noradrenaline -> hypotension
  • muscle spasms -> benzodiazepines
  • seizures -> benzodiazepine, phenytoin and phenobarbital

Underlying Cause

  • psychiatric referral

CCC Toxicology Series

CCC 700 6

Critical Care

Compendium

Chris is an Intensivist and ECMO specialist at The Alfred ICU, where he is Deputy Director (Education). He is a Clinical Adjunct Associate Professor at Monash University, the Lead for the  Clinician Educator Incubator programme, and a CICM First Part Examiner.

He is an internationally recognised Clinician Educator with a passion for helping clinicians learn and for improving the clinical performance of individuals and collectives. He was one of the founders of the FOAM movement (Free Open-Access Medical education) has been recognised for his contributions to education with awards from ANZICS, ANZAHPE, and ACEM.

His one great achievement is being the father of three amazing children.

On Bluesky, he is @precordialthump.bsky.social and on the site that Elon has screwed up, he is @precordialthump.

| INTENSIVE | RAGE | Resuscitology | SMACC

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.